Éric Jeziorski
Centre de Référence des Maladies Autoinflammatoires et des Amyloses(FR)Epidemic Intelligence Service(US)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Blood groups and transfusion, Parvovirus B19 Infection Studies, Histiocytic Disorders and Treatments
Most-Cited Works
- → BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy(2016)330 cited
- → Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies(2017)309 cited
- → Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children(2016)234 cited
- → A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis)(2016)221 cited
- → Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients(2020)199 cited
- → A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation(2011)178 cited